Budd-Chiari syndrome risk factors
Budd-Chiari syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Budd-Chiari syndrome risk factors On the Web |
American Roentgen Ray Society Images of Budd-Chiari syndrome risk factors |
Risk calculators and risk factors for Budd-Chiari syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overivew
Approximately 80 percent of patients with the Budd-Chiari syndrome have an underlying disorder. Many patients may have more than one risk factor. Same patients may have multiple causes that predispose to the development of Budd-Chiari Syndrome. Associated risk factors include hematologic disorders, coagulopathies, chronic infections, chronic inflammatory diseases, tumors, congenital membranous obstructions.
Risk Factors
- Approximately 80 percent of patients with the Budd-Chiari syndrome have an underlying disorder. Many patients may have more than one risk factor. Same patient may have multiple causes that predispose to the development of Budd-Chiari Syndrome.[1][2]
- Associated risk factors include:
- Hematologic disorders including:
- Coagulopathies include the following:
- Chronic infections like:
- Chronic inflammatory diseases such as:
- Tumors such as
- Congenital membranous obstructions that include the following:
- Type I: Thin membrane is present in the vena cava or the atrium
- Type II: A part of the vena cava is absent
- Type III: The inferior vena cava (IVC) cannot be filled, and collaterals have developed
- Miscellaneous risk factors of Budd-Chiari syndrome include the following:
- Alpha1-antitrypsin deficiency
- Dacarbazine
- Urethane
- Hypoplasia of the suprahepatic veins
- Postsurgical obstruction
- Posttraumatic obstruction
- Total parenteral nutrition (TPN): Budd-Chiari syndrome can be a complication of total parenteral nutrition (TPN) via an inferior vena cava (IVC) catheter in a neonate
References
- ↑ Martens P, Nevens F (2015). "Budd-Chiari syndrome". United European Gastroenterol J. 3 (6): 489–500. doi:10.1177/2050640615582293. PMC 4669515. PMID 26668741.
- ↑ Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS (2016). "Redefining Budd-Chiari syndrome: A systematic review". World J Hepatol. 8 (16): 691–702. doi:10.4254/wjh.v8.i16.691. PMC 4909431. PMID 27326316.